This content is from: IP Strategy

How patent evergreening plays out in India

Pharma counsel analyse the relevant provision to curb patent evergreening in India and its recent application by the patent office and the courts

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial